(NasdaqGM:AMOD),(NasdaqGM:AMODW), CORNELIUS, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Alpha Modus”, “AMOD”, or the “Company”), in a statement today, through Alpha Modus CEO William Alessi, emphasized the company's strong fundamentals, ongoing growth strategy, and commitment to delivering value to shareholders amidst what he described as “uninformed speculation” by certain […]
(Other OTC:RLNDF),(OTC US:RLNDF), Hamilton, Bermuda and Paris, France, Jan. 30, 2025 (GLOBE NEWSWIRE) — The RoyaLand Company Ltd. (OTCQB: RLNDF) (“RoyaLand” or the “Company”), a Bermuda holding company focused on creating an online and offline immersive, fantasy-based royalty-themed game called TheRoyal.Land, today announced the introduction of a mobile companion application for TheRoyal.Land. RoyaLand's companion app
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Indicium, a global data services consultancy, announces the Unity Catalog Migration, a new solution enabling unified governance of data and AI assets within Databricks, simplifying access, compliance and management across an organization. Large enterprises face fragmented data governance and compliance risks, and inefficiencies in metadata management, often
(NASDAQ:RVPH),(NASDAQ:RVPH), CUPERTINO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of
(NasdaqGM:ALLR), Boston (January 30, 2025)–Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments using its proprietary, drug-specific patient selection technology, has filed a Form 8-K with the U.S. Securities and Exchange Commission (“SEC”) regarding its agreement in principle with the SEC staff to
(NASDAQ:PXS), Maroussi, Greece – January 30, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, announced today key shareholder and chartering updates. The Company has completed its authorized expanded $3.0 million common share repurchase program. Since summer 2023, we have acquired 730,683 common
(NASDAQ:EVAX), COPENHAGEN, Denmark, January 30, 2025 – Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines, today announced the pricing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares (“ADSs”) and warrants to purchase up to 50% of the ADSs offered at a
Zurich, Jan. 30, 2025 (GLOBE NEWSWIRE) — When Fajer Mushtaq turned on the tap as a child in Delhi, one question always loomed: was the water safe? Today, that same question haunts communities worldwide as PFAS — toxic “forever chemicals” used in everything from non-stick pans to firefighting foam — contaminate water supplies at an
The following issues have been halted by CIRO: Company: Numinus Wellness Inc. TSX Symbol: NUMI All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair
Herndon, Virginia, Jan. 30, 2025 (GLOBE NEWSWIRE) — Serco, a provider of professional, technology, engineering, and management services, has today announced that it has agreed to acquire Northrop Grumman's mission training and satellite ground network communications software business (MT&S). Adding to Serco's existing defense capabilities, MT&S provides the U.S. military with advanced mission training services,